More than 1 lakh bottles of its hypertension drug metoprolol has been recalled from the US market by Mumbai-based pharmaceutical company Wockhardt, the US Food and Drug Administration revealed.
The move comes after two of Wockhardt facilities at Chikalthana and Waluj in Aurangabad had been barred by the FDA from exporting drugs to the US.
According to the FDA, the bottles have been recalled after they failed the dissolution test, which measures the time taken by a drug to be absorbed by the body.
Latest Drug News
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.
In myeloma (blood cancer) cells, cancer-promoting potential of the fatty acid binding proteins was found to determine to be a valid target for myeloma therapeutics
Acute liver failure cases dropped after the Food and Drug Administration rule to lower the dosage of acetaminophen